* Crossposted from: Fibromyalgia/Fibrositis Discussion Area
NEW TREATMENT FOR SJOGREN'S SYNDROME (DRY MOUTH)
April 6, 1998
The U.S. Congress has designated April as "Sjogren's Awareness Month,"
which coincides nicely with the release of a new drug, Salagen, which
treats the dry mouth associated with the disease.  Sjogren's Syndrome is a
chronic inflammatory autoimmune disease that gradually damages the
moisture-producing glands throughout the body, resulting in extreme
dryness.  An estimated one million Americans have it, including many CFS
patients.
Salagen (pilocarpine hydrochloride), which is marketed by MGI Pharma, is
intended to treat the overall dry mouth problem, improving patients'
ability to speak, swallow and sleep.  The FDA approved the drug in February
and MGI Pharma is now launching a marketing campaign.
For more information about Sjogren's Syndrome, you can contact:
The Sjogren's Syndrome Foundation.  Phone:  800-4-SJOGREN, or website:
www.sjogrens.com
The National Sjogren's Syndrome Association.  Phone: 800-395-6772, or
website:  www.sjogrens.org.
Source:  PRNewswire
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
 cfsmail@earthlink.net
http://home.earthlink.net/~cfsmail/
cfsmail is a free email news service for chronic fatigue syndrome
and fibromyalgia.  To subscribe, send an email to the above
address or click on "subscribe to cfsmail" at the website.
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *
   --Bill
     Fidonet Netmail: 1:280/76
     E-Mail: cfsdays@oz.sunflower.org
     CFS DAYS Home Page:  http://www.sunflower.org/~cfsdays/cfsdays.htm
-+- OLMS 2.53 UNREG
---
 
---------------